| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 2 | +1.47M | 49.3% | $18.99 | +$27.9M |
| Sells | 10 | -1.51M | 50.7% | $13.04 | -$19.7M |
| Net | -8 | -39.5K | -1.3% | +$8.24M |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| GSK plc | 10%+ Owner | $347M | +$27.9M | +8.76% | 11 Dec 2025 |
| RA CAPITAL MANAGEMENT, L.P. | Director, 10%+ Owner | $122M | +$6.69K | +0.01% | 13 Nov 2025 |
| KEN TAKANASHI | Director | $44.1M | -$42.6K | -0.1% | 11 Aug 2025 |
| Gregory L. Verdine | Director | $3.87M | -$578K | -13% | 08 Dec 2025 |
| Kyle Moran | Chief Financial Officer | $1.81M | -$4.1M | -69.4% | 08 Dec 2025 |
| PAUL BOLNO | President and CEO, Director | $1.22M | -$3.81M | -75.7% | 22 Aug 2025 |
| Chandra Vargeese | Chief Technology Officer, Head of Platform Discovery Sciences | $899K | 04 Mar 2025 | ||
| Heidi Wagner | Director | $629K | -$189K | -23.1% | 08 Dec 2025 |
| MARK CORRIGAN | Director | $405K | -$217K | -34.9% | 08 Dec 2025 |
| Chris Francis | SVP, Corporate Development, Head of Emerging Areas | $352K | -$6.43M | -94.8% | 08 Dec 2025 |
| Aik Na Tan | Director | $324K | -$2.03M | -86.2% | 08 Dec 2025 |
| CHRISTIAN HENRY | Director | $229K | -$1.56M | -87.2% | 08 Dec 2025 |
| Adrian Rawcliffe | Director | $191K | -$739K | -79.5% | 08 Dec 2025 |
| Michael A. Panzara | Chief Medical Officer, Head of Therapeutics Discovery and Development | 25 Jul 2022 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|